Trials / Completed
CompletedNCT02503189
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KCT-0809 ophthalmic solution | |
| DRUG | Placebo |
Timeline
- Primary completion
- 2017-01-01
- First posted
- 2015-07-20
- Last updated
- 2017-05-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02503189. Inclusion in this directory is not an endorsement.